Various other studies had compared oral to intravenous iron for managing anaemia in patients with chronic kidney disease who were not on dialysis and concluded with increases in both Hb and ferritin following IV iron therapy rather than with oral iron [21-30]. The gene discussed is GSTM1; the disease is chronic kidney disease.